# A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

> **NCT01469065** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 82 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-04991532
- **DRUG:** PF-04991532
- **DRUG:** PF-04991532
- **DRUG:** PF-0499132
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01469065
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469065, "A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01469065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*